de Salazar, L.; Segarra, I.; López-Román, F.J.; Torregrosa-García, A.; Pérez-Piñero, S.; Ávila-Gandía, V.
Increased Bioavailability of β-Alanine by a Novel Controlled-Release Powder Blend Compared to a Slow-Release Tablet. Pharmaceutics 2021, 13, 1517.
https://doi.org/10.3390/pharmaceutics13091517
AMA Style
de Salazar L, Segarra I, López-Román FJ, Torregrosa-García A, Pérez-Piñero S, Ávila-Gandía V.
Increased Bioavailability of β-Alanine by a Novel Controlled-Release Powder Blend Compared to a Slow-Release Tablet. Pharmaceutics. 2021; 13(9):1517.
https://doi.org/10.3390/pharmaceutics13091517
Chicago/Turabian Style
de Salazar, Lydia, Ignacio Segarra, Francisco Javier López-Román, Antonio Torregrosa-García, Silvia Pérez-Piñero, and Vicente Ávila-Gandía.
2021. "Increased Bioavailability of β-Alanine by a Novel Controlled-Release Powder Blend Compared to a Slow-Release Tablet" Pharmaceutics 13, no. 9: 1517.
https://doi.org/10.3390/pharmaceutics13091517
APA Style
de Salazar, L., Segarra, I., López-Román, F. J., Torregrosa-García, A., Pérez-Piñero, S., & Ávila-Gandía, V.
(2021). Increased Bioavailability of β-Alanine by a Novel Controlled-Release Powder Blend Compared to a Slow-Release Tablet. Pharmaceutics, 13(9), 1517.
https://doi.org/10.3390/pharmaceutics13091517
